Construction of a positive selection marker by a lethal gene with the amber stop codon(s) regulator

Bioscience, Biotechnology and Biochemistry

Volumn 70, Issue 1, 2006, Pages 119-125

  Ohashi Kunihiro, Sumiko ^a,b   Hagiwara, Hiroko ^a   Yohda, Masafumi ^b   Masaki, Haruhiko ^c   Machida, Masayuki ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Amber stop codon; C terminal ribonuclease domain (CRD); Colicin E3; Positive selection; Suppressor activity

Indexed keywords

DNA; ENCODING (SYMBOLS); ESCHERICHIA COLI; TOXICITY; VECTORS;

AMBER STOP CODON; C-TERMINAL RIBONUCLEASE DOMAIN (CRD); COLICIN E3; POSITIVE SELECTION; SUPPRESSOR ACTIVITY;

GENES;

ARTICLE; BACTERIUM TRANSFORMATION; ESCHERICHIA COLI; GENE VECTOR; GENETIC MARKER; GENETIC SELECTION; GENETICS; LETHAL GENE; STOP CODON; SUPPRESSOR GENE;

CODON, TERMINATOR; ESCHERICHIA COLI; GENES, LETHAL; GENES, SUPPRESSOR; GENETIC MARKERS; GENETIC VECTORS; SELECTION (GENETICS); TRANSFORMATION, BACTERIAL;

ENTEROBACTERIA PHAGE LAMBDA; ESCHERICHIA COLI;

EID: 31444457034     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.70.119     Document Type: Article

References (38)

1. Bernard, P., and Couturier, M., Cell killing by the F plasmid CcdB protein involves poisoning of DNA-topoisomerase II complexes. J. Mol. Biol., 226, 735-745 (1992).
2. Bernard, P., Gabant, P., Bahassi, E. M., and Couturier, M., Positive-selection vectors using the F plasmid ccdB killer gene. Gene, 148, 71-74 (1994).
3. Bernard, P., and Couturier, M., The 41 carboxy-terminal residues of the miniF plasmid CcdA protein are sufficient to antagonize the killer activity of the CcdB protein. Mol. Gen. Genet., 226, 297-304 (1991).
4. Bernard, P., Kezdy, K. E., Van Melderen, L., Steyaert, J., Wyns, L., Pato, M. L., Higgins, P. N., and Couturier, M., The F plasmid CcdB protein induces efficient ATP-dependent DNA cleavage by gyrase. J. Mol. Biol., 234, 534-541 (1993).
5. Bowman, C. M., Sidikaro, J., and Nomura, M., Specific inactivation of ribosomes by colicin E3 in vitro and mechanism of immunity in colicinogenic cells. Nat. New Biol., 234, 133-137 (1971).
6. Bowman, C. M., Dahlberg, J. E., Ikemura, T., Konisky, J., and Nomura, M., Specific inactivation of 16S ribosomal RNA induced by colicin E3 in vivo. Proc. Natl. Acad. Sci. U.S.A., 68, 964-968 (1971).
7. Ohno, S., and Imahori, K., Colicin E3 is an endonuclease. J. Biochem. (Tokyo), 84, 1637-1640 (1978).
8. Senior, B. W., and Holland, I. B., Effect of colicin E3 upon the 30S ribosomal subunit of Escherichia coli. Proc. Natl. Acad. Sci. U.S.A., 68, 959-963 (1971).
9. Boon, T., Inactivation of ribosomes in vitro by colicin E 3. Proc. Natl. Acad. Sci. U.S.A., 68, 2421-2425 (1971).
10. Jakes, K., "Molecular Action of Toxins and Viruses", eds. Cohen, P., and Van Heyningen, S., Elsevier Biomedical Press, pp. 131-167 (1982).
11. Konisky, J., Colicins and other bacteriocins with established modes of action. Annu. Rev. Microbiol., 36, 125-144 (1982).
12. Lau, P. C., Rowsome, R. W., Zuker, M., and Visentin, L. P., Comparative nucleotide sequences encoding the immunity proteins and the carboxyl-terminal peptides of colicins E2 and E3. Nucl. Acids Res., 12, 8733-8745 (1984).
13. Masaki, H., and Ohta, T., A plasmid region encoding the active fragment and the inhibitor protein of colicin E3 - CA38. FEBS Lett., 149, 129-132 (1982).
14. Mock, M., Miyada, C. G., and Gunsalus, R. P., Nucleotide sequence for the catalytic domain of colicin E3 and its immunity protein: evidence for a third gene overlapping colicin. Nucl. Acids Res., 11, 3547-3557 (1983).
15. Jakes, K., Zinder, N. D., and Boon, T., Purification and properties of colicin E3 immunity protein. J. Biol. Chem., 249, 438-444 (1974).
16. Jakes, K. S., The mechanism of action of colicin E2, colicin E3 and cloacin DF13. In "Action of Toxins and Viruses", eds. Cohen, P., and Van Heyningen, S., Elesevier, Amsterdam, pp. 131-167 (1982).
17. Jakes, K. S., and Zinder, N. D., Highly purified colicin E3 contains immunity protein. Proc. Natl. Acad. Sci. U.S.A., 71, 3380-3384 (1974).
18. Masaki, H., and Ohta, T., Colicin E3 and its immunity genes. J. Mol. Biol., 182, 217-227 (1985).
19. Mochitate, K., Suzuki, K., and Imahori, K., Amino acid sequence of immunity protein (B subunit) of colicin E3. J. Biochem. (Tokyo), 89, 1609-1618 (1981).
20. Ohno, S., Ohno-Iwashita, Y., Suzuki, K., and Imahori, K., Purification and characterization of active component and active fragment of colicin E3. J. Biochem. (Tokyo), 82, 1045-1053 (1977).
21. Ohno-Iwashita, Y., and Imahori, K., Assignment of the functional loci in colicin E2 and E3 molecules by the characterization of their proteolytic fragments. Biochemistry, 19, 652-659 (1980).
22. Suzuki, K., Ohno, S., and Imahori, K., Studies on the physicochemical structure and stability of an active fragment (T2A) of colicin E3. J. Biochem. (Tokyo), 87, 761-769 (1980).
23. Suzuki, K., and Imahori, K., Preparation and characterization of an active fragment of colicin E3. J. Biochem. (Tokyo), 84, 1021-1029 (1978).
24. Ozaki, L. S., Maeda, S., Shimada, K., and Takagi, Y., A novel ColE1::Tn3 plasmid vector that allows direct selection of hybrid clones in E. coli. Gene, 8, 301-314 (1980).
25. Vernet, T., Lau, P. C., Narang, S. A., and Visentin, L. P., A direct-selection vector derived from pColE3-CA38 and adapted for foreign gene expression. Gene, 34, 87-93 (1985).
26. Niwa, M., Maruyama, H., Fujimoto, T., Dohi, K., and Maruyama, I. N., Affinity selection of cDNA libraries by lambda phage surface display. Gene, 256, 229-236 (2000).
27. Reha-Krantz, L. J., The Escherichia coli strain JM105 contains partial supE activity. Gene, 38, 275-276 (1985).
28. Akutsu, A., Masaki, H., and Ohta, T., Molecular structure and immunity specificity of colicin E6, an evolutionary intermediate between E-group colicins and cloacin DF13. J. Bacteriol., 171, 6430-6436 (1989).
29. Toba, M., Masaki, H., and Ohta, T., Primary structures of the ColE2-P9 and ColE3-CA38 lysis genes. J. Biochem. (Tokyo), 99, 591-596 (1986).
30. Cheng, X., Kay, B. K., and Juliano, R. L., Identification of a biologically significant DNA-binding peptide motif by use of a random phage display library. Gene, 171, 1-8 (1996).
31. Christian, R. B., Zuckermann, R. N., Kerr, J. M., Wang, L., and Malcolm, B. A., Simplified methods for construction, assessment and rapid screening of peptide libraries in bacteriophage. J. Mol. Biol., 227, 711-718 (1992).
32. Hagiwara, H., Kunihiro, S., Nakajima, K., Sano, M., Masaki, H., Yamamoto, M., Pak, J. W., Zhang, Y., Takase, K., Kuwabara, I., Maruyama, I. N., and Machida, M., Affinity selection of DNA-binding proteins from yeast genomic DNA libraries by improved lambda phage display vector. J. Biochem. (Tokyo), 132, 975-982 (2002).
33. Yamamoto, K. R., Alberts, B. M., Benzinger, R., Lawhorne, L., and Treiber, G., Rapid bacteriophage sedimentation in the presence of polyethylene glycol and its application to large-scale virus purification. Virology, 40, 734-744 (1970).
34. Machida, M., Gonzalez, T. V., Boon, L. K., Gomi, K., and Jigami, Y., Molecular cloning of a genomic DNA for enolase from Aspergillus oryzae. Biosci. Biotechnol. Biochem., 60, 161-163 (1996).
35. Toda, T., Sano, M., Honda, M., Rimoldi, O. J., Yang, Y., Yamamoto, M., Takase, K., Hirozumi, K., Kitamoto, K., Minetoki, T., Gomi, K., and Machida, M., Deletion analysis of the enolase gene (enoA) promoter from the filamentous fungus Aspegillus oryzae. Curr. Genet., 40, 260-267 (2001).
36. Laughon, A., and Gesteland, R. F., Primary structure of the Saccharomyces cerevisiae GAL4 gene. Mol. Cell. Biol., 4, 260-267 (1984).
37. Maruyama, I. N., Maruyama, H. I., and Brenner, S., Lambda foo: a lambda phage vector for the expression of foreign proteins. Proc. Natl. Acad. Sci. U.S.A., 91, 8273-8277 (1994).
38. Kuwabara, I., Maruyama, H., Kamisue, S., Shima, M., Yoshioka, A., and Maruyama, I. N., Mapping of the minimal domain encoding a conformational epitope by lambda phage surface display: factor VIII inhibitor antibodies from haemophilia A patients. J. Immunol. Methods, 224, 89-99 (1999).